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Abstract Nuclear factor UB (NF-UB)-dependent gene expres-
sion plays an important role in numerous cellular processes in-
cluding stress responses, in£ammation and cell proliferation.
Therefore, the activity of this transcription factor needs to be
tightly regulated. Among others, the NF-UB-dependent zinc ¢n-
ger protein A20 is involved in the negative feedback regulation
of NF-UB activation in response to tumor necrosis factor (TNF).
We previously demonstrated that A20 can interact with A20-
binding inhibitors of NF-UB activation (ABINs), which have the
potential to inhibit TNF-induced activation of NF-UB upon
overexpression. The ABIN proteins were therefore proposed to
mediate the NF-UB inhibiting function of A20. Here we demon-
strate the presence of a short homologous region in ABINs and
IUB kinase Q, the regulatory subunit of the IUB kinase complex.
Site-speci¢c mutagenesis of this region abolished the NF-UB
inhibiting function of ABIN-1, without a¡ecting the interaction
with A20. Furthermore, coexpression of these ABIN-1 mutants
interfered in a dominant negative manner with the NF-UB in-
hibiting function of ABIN-1, whereas the A20-mediated inhibi-
tion was una¡ected. These results suggest that A20 and ABIN-1
probably act independently of their mutual interaction.
- 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The transcription factor nuclear factor UB (NF-UB) is one
of the main regulators involved in in£ammatory responses, as
well as several other cellular functions including cell growth
and di¡erentiation. Uncontrolled NF-UB activity is a major
hallmark of several in£ammatory diseases. Therefore, activa-
tion of this transcription factor is tightly regulated and is only
transient. Negative feedback regulation of NF-UB activity re-
quires, besides the well studied NF-UB interacting protein
IUB, also the zinc ¢nger protein A20: mice de¢cient for A20
develop cachexia, are hyperresponsive to tumor necrosis fac-
tor (TNF) and su¡er from severe in£ammation correlated
with enhanced NF-UB activity [1]. A20 is a primary response
gene that was originally identi¢ed as a cytokine-inducible gene
in human umbilical vein endothelial cells, and which encodes
a protein of approximately 80 kDa of which the C-terminal
domain consists of seven Cys2/Cys2 zinc ¢nger structures [2].
In the meantime, A20 has been shown to be an NF-UB-re-
sponsive gene that can be induced in several cell lines by a
variety of stimuli including TNF, interleukin-1 (IL-1), bacte-
rial lipopolysaccharide (LPS), the B-cell surface receptor
CD40, phorbol 12-myristate 13-acetate, as well as by over-
expression of the Epstein^Barr virus LMP1 protein and the
human T-cell leukemia virus Tax protein [2^6].
Although A20 was originally described as an inhibitor of
TNF-induced apoptosis [7], it is best characterized as a potent
cellular inhibitor of NF-UB activation [8^12]. However, the
underlying molecular mechanisms still remain largely un-
known. A20 has been described to interact with the TNF
receptor-associating factors TRAF1 and TRAF2 [13]. The
latter proteins form an oligomeric complex that associates
with the cytoplasmic domains of various members of the
TNF receptor superfamily. Gene targeting studies indicated
that TRAF2 is required for optimal TNF-induced activation
of the IUB kinase (IKK) complex [14]. The latter complex
contains two catalytic subunits, IKKK and IKKL, which
upon activation phosphorylate the NF-UB inhibiting protein
IUB, making IUB a substrate for ubiquitination and proteaso-
mal degradation, thus allowing translocation of NF-UB to the
nucleus [15]. Another core component of the IKK complex is
the regulatory subunit IKKQ, which upon TNF triggering in-
teracts with the death domain kinase RIP (receptor interacting
protein), resulting in dimerization and activation of the IKK
complex [16,17]. More recently, A20 was also shown to inter-
act with IKKQ in a TNF-dependent manner [18]. However,
direct interaction of A20 with TRAF proteins or with IKKQ is
probably not su⁄cient for its NF-UB inhibiting function:
structure^function studies using deletion mutants of A20 in-
dicated that interaction of A20 with these NF-UB intermedi-
ates is mediated by the N-terminal, non-zinc ¢nger-containing
part of A20 or with the N-terminal domain extended by one
zinc ¢nger, respectively, whereas the C-terminal zinc ¢nger-
containing part of A20 containing at least four zinc ¢nger
structures is essential for inhibition of NF-UB activation
[13,19]. Yeast two-hybrid studies revealed the binding of the
zinc ¢nger domain of A20 with two novel proteins, named
ABIN-1 (previously called ABIN, for A20-binding inhibitor
of NF-UB activation) and ABIN-2 [9,20]. Overexpression of
each ABIN protein mimics the NF-UB inhibiting e¡ect of
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A20, suggesting that this function of A20 may at least par-
tially be mediated by ABINs. In the present study, we provide
evidence that interaction of A20 and ABIN-1 is not essential
for TNF-induced NF-UB inhibition.
2. Materials and methods
2.1. Cell lines and reagents
Human embryonic kidney HEK293T cells were a kind gift of Dr.
M. Hall (Department of Biochemistry, University of Birmingham,
UK). Cells were grown in Dulbecco’s modi¢ed Eagle’s medium sup-
plemented with 10% fetal bovine serum, 2 mM L-glutamine, 0.4 mM
sodium pyruvate and antibiotics. Recombinant human TNF was ex-
pressed in Escherichia coli, puri¢ed to at least 99% homogeneity and
had a speci¢c biological activity of 2.3U107 IU/mg puri¢ed protein,
as determined with the international standard (code 87/650; National
Institute for Biological Standards and Control, Potters Bar, UK).
Monoclonal anti-E tag antibody and monoclonal anti-E tag horse-
radish peroxidase-linked antibody were obtained from Amersham
Pharmacia Biotech (Uppsala, Sweden), monoclonal anti-FLAG horse-
radish peroxidase-linked antibody from Sigma-Aldrich (St. Louis,
MO, USA), monoclonal anti-HA antibody from CRP (Richmond,
CA, USA). Anti-mouse horseradish peroxidase-linked antibodies
were obtained from Amersham Pharmacia Biotech.
2.2. Expression vectors
The eukaryotic expression vectors pUT651, pNFconluc, pCAGGS-
E-A20, pCAGGS-FLAG-A20, pCAGGS-E-ABIN-1 have been de-
scribed earlier [9,19,21,22]. The vector pCAGGS-HA-ABIN-1 was
obtained by cloning the full-length coding sequence of ABIN-1 in
frame with an N-terminally located HA tag in the eukaryotic expres-
sion vector pCAGGS. Fragments of ABIN-1 were ampli¢ed by poly-
merase chain reaction (PCR) using speci¢c primers and were cloned in
frame with an N-terminal E tag in pCAGGS. Site-speci¢c mutations
in ABIN-1 were introduced by overlap PCR using speci¢c primers (5P-
GTTGCTGAAAGAGGACGTCAAAATCTTTGA-3P for ABIN-1-
MUT1; 5P-GCAGGTAAAAATCTTTGAAGAGAATGCCCAGA-
GGGAACG-3P for ABIN-1-MUT2; 5P-GCAGGTAAAAATCTT-
TGAAGAGGACTTCCAGAGGGAACG-3P for ABIN-1-MUT3).
Mutated ABIN-1 cDNAs were cloned in the eukaryotic expression
vector pCAGGS C-terminal of the E tag.
2.3. Coimmunoprecipitation and Western blotting
HEK293T cells (1.5U106) were plated on 10-cm Petri dishes and
transfected by calcium phosphate precipitation with 5 Wg of expres-
sion plasmids. Twenty-four hours after transfection cells were lysed in
500 Wl of lysis bu¡er (50 mM HEPES pH 7.6, 250 mM NaCl, 0.1%
Nonidet P-40 and 5 mM EDTA, supplemented with protease and
phosphatase inhibitors). Lysates were incubated with the indicated
antibodies and immobilized protein A on Trisacryl (Pierce Chemicals,
Rockford, IL, USA). Beads were washed twice with lysis bu¡er, twice
with lysis bu¡er containing 1 M NaCl and twice with lysis bu¡er.
Coprecipitating proteins were separated by SDS^PAGE and analyzed
by Western blotting using ECL detection (Perkin Elmer Life Scien-
ces).
2.4. NF-UB reporter gene assay
HEK293T cells were seeded in 24-well plates and transiently trans-
fected by a standard calcium phosphate coprecipitation method using
200 ng DNA per well. Each transfection contained 20 ng of pNFcon-
luc plasmid and 20 ng pUT651 plasmid. Twenty-four hours after
transfection cells were either stimulated with 1000 IU/ml hTNF or
left untreated. After 6 h stimulation, cells were lysed in 200 Wl lysis
bu¡er and NF-UB-dependent luciferase activity was measured as pre-
viously described [22]. Constitutively expressed L-galactosidase activ-
ity was measured to normalize for di¡erences in transfection e⁄-
ciency.
3. Results and discussion
3.1. A region that is conserved between ABINs and IKKQ is
necessary but not su⁄cient for the NF-UB inhibiting
function of ABIN-1
The underlying mechanism of negative feedback regulation
of NF-UB activation by A20 is still unclear. Structure^func-
tion analysis of A20 indicated that similar domains of A20 are
required for the NF-UB inhibiting potential of A20 as well as
for its interaction with the NF-UB inhibiting proteins ABIN-1
and ABIN-2. Therefore ABIN proteins might at least partially
mediate the e¡ect of A20 [19]. Amino acid sequence compar-
ison of the A20 interacting proteins ABIN-1 and ABIN-2
indicated the presence of two homologous regions of approx-
imately 20 amino acids, further designated AHD1 and AHD2
(ABIN homology domain [20]). PSI-BLAST searches at
NCBI led to the identi¢cation of a homologous AHD2 se-
quence in the C-terminal part of IKKQ, as well as in LIND
(which we refer to as ABIN-3) and the IKKQ-related protein,
NRP [23,24]. Furthermore, for these proteins the AHD2
Fig. 1. Sequence alignment of the conserved AHD2 region found in ABIN-1, ABIN-2, LIND/ABIN-3, IKKQ and NRP of di¡erent species.
Identical and homologous amino acid residues present in all proteins of the di¡erent species are indicated in bold or underlined, respectively
(Bt: Bos taurus ; Dm: Drosophila melanogaster ; Gg: Gallus gallus ; Hs: Homo sapiens ; Mf: Macaca fascicularis ; Mm: Mus musculus ; Rn: Rat-
tus norvegicus). Also the sequence of the AHD2 domain of the IKKQ(D311N) mutant, found in a family su¡ering from X-linked anhydrotic ec-
todermal dysplasia with immunode¢ciency, is indicated [25].
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sequence is highly conserved throughout di¡erent species
(Fig. 1).
To unravel the importance of this AHD2 sequence in
ABIN-1, deletion mutagenesis and site-speci¢c mutagenesis
was applied. Previously we demonstrated that the NF-UB in-
hibiting function is located in the C-terminal part of ABIN-1
(aa 390^647) that contains this homology sequence. Therefore
we generated further N- and C-terminal deletion mutants
starting from ABIN-1(390^647) (Fig. 2A). On the other
hand, three site-speci¢c mutants of ABIN-1, indicated by
the extensions MUT1, MUT2 and MUT3, were made in
which each time two conserved amino acids of AHD2 were
replaced (Fig. 2B).
To analyze the contribution of AHD2 to the NF-UB inhib-
iting e¡ects of ABIN-1, we transiently transfected HEK293T
cells with expression plasmids encoding ABIN-1, ABIN-1 de-
letion mutants or ABIN-1-MUTs and studied their e¡ects on
TNF-induced activation of NF-UB by luciferase reporter tests.
Overexpression of deletion mutants of ABIN-1 indicated that
the shortest ABIN-1 fragment that still inhibits TNF-induced
NF-UB activation was composed of amino acids 444^601 con-
taining the AHD2 domain with an extra 30 amino acids
N-terminally and 105 amino acids C-terminally (Fig. 2C).
Further N- or C-terminal deletions abolished this function
indicating that besides the AHD2 sequence N- and C-terminal
sequences are required for the function of ABIN-1. In addi-
tion, AHD2 site-speci¢c mutants of ABIN-1 were not able to
inhibit TNF-induced activation of NF-UB, even at high ex-
pression levels (Fig. 2D), demonstrating an essential role for a
short region (AHD2) in ABIN-1 that is closely related to a
region in the C-terminal part of IKKQ, as well as to a region
in ABIN-2, ABIN-3 and NRP [20,23,24]. Whereas overexpres-
sion of ABIN-1, ABIN-2 or ABIN-3 abrogates TNF-induced
NF-UB activation, no e¡ect was observed upon overexpres-
sion of NRP ([9,20,24] ; our unpublished data). Interestingly,
in families su¡ering from X-linked anhydrotic ectodermal dys-
plasia with immunode¢ciency, a disease correlated with im-
paired NF-UB signalling, several point mutations in the
C-terminus of IKKQ have been found. One of these mutations
corresponds to a conserved aspartic acid residue in AHD2,
suggesting also an important role of this homologous region
in IKKQ [25]. Taking into account the above ¢ndings we hy-
pothesize that ABIN-1 competes with IKKQ for an upstream
IKKQ activator that binds the AHD2 region. However, acti-
vation mechanisms of IKKQ are still largely unclear. A role
for RIP, CIKS/Act1 and TANK/I-TRAF has been proposed,
 
 
 
 
 
 
Fig. 2. Structure^function analysis of the NF-UB inhibiting capacity of ABIN-1. A: Schematic overview of deletion mutants of ABIN-1. Ho-
mologous regions AHD1 and AHD2 are indicated. B: Comparison of AHD2 sequences of ABIN-1, ABIN-2 and IKKQ. Identical amino acids
are indicated in bold. Conserved amino acids were mutated in the AHD2 sequence of ABIN-1 by overlap PCR, generating ABIN-1-MUT1,
ABIN-1-MUT2 and ABIN-1-MUT3 (mutated amino acids are underlined), and con¢rmed by sequence analysis. C,D: E¡ect of ABIN-1 mu-
tants on TNF-induced NF-UB activation. HEK293T cells were transiently transfected with 20 ng expression vectors encoding the di¡erent
ABIN-1 mutants together with 20 ng pNFconluc and 20 ng pUT651. After 24 h, cells were left untreated (open bars) or stimulated for 6 h
with 1000 IU/ml TNF (¢lled bars). NF-UB activity was determined via luciferase and L-galactosidase reporter gene tests and is shown as luc/
gal values. Results are representative of at least three independent experiments. Each bar represents the mean of three samples.
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Fig. 3. Coexpression of ABIN-1 AHD2 site-speci¢c mutants interferes in a dominant negative manner with the NF-UB inhibiting function of
wild type ABIN-1. To analyze if overexpression of the site-speci¢c mutants of ABIN-1 interfered with the NF-UB inhibiting function of wild
type ABIN-1 or A20, an excessive amount of E-tagged ABIN-1-MUTs (40 ng) was cotransfected with either HA-tagged ABIN-1 (20 ng) or
FLAG-tagged A20 (20 ng) in HEK293T cells. Cells were left untreated (open bars) or stimulated with 1000 IU/ml TNF (¢lled bars) for 6 h.
Cells were lysed and NF-UB-dependent luciferase reporter gene expression and constitutive L-galactosidase expression were analyzed. Each luc/
gal value represents the mean of three samples (A). The corresponding expression levels were analyzed by Western blotting (B). Results are rep-
resentative of at least three independent experiments.
Fig. 4. Interaction of ABIN-1 mutants with A20. 1.5U106 HEK293T cells were transiently transfected with 1 Wg pCAGGS-FLAG-A20 together
with 1 Wg empty vector or pCAGGS vectors encoding ABIN-1 deletion (A) or site-speci¢c mutants (B). Twenty-four hours after transfection,
ABIN-1 variants were immunoprecipitated using anti-E tag antibodies, and the presence of coimmunoprecipitated A20 was revealed by immu-
noblotting using anti-FLAG antibodies, as shown in the upper panels. Aliquots of total lysates were analyzed to con¢rm expression of trans-
fected ABIN-1 proteins or A20 using anti-E tag and anti-FLAG tag, respectively, as shown in the lower panels. The cause of the appearance
of multiple bands after overexpression of ABIN-1(390^647), ABIN-1(420^647), ABIN-1(444^647) and ABIN-1(469^647) is still unclear.
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but these proteins interact with an intermediate domain of
IKKQ [18,26,27]. So far no IKKQ-activating signalling inter-
mediate that speci¢cally binds to the AHD2 region has been
identi¢ed.
3.2. Coexpression of ABIN-1 AHD2 mutants prevents the
NF-UB inhibiting function of ABIN-1
Since AHD2 site-speci¢c mutants of ABIN-1 were unable
to inhibit TNF-induced activation of NF-UB, we analyzed if
these mutants can interfere in a dominant negative manner
with the NF-UB inhibiting e¡ects of ABIN-1 or A20. There-
fore an excessive amount of plasmids containing these
E-tagged ABIN-1-MUTs was cotransfected with expression
vectors containing HA-tagged ABIN-1 or FLAG-tagged
A20 in HEK293T cells. NF-UB activation was analyzed in a
luciferase reporter test after stimulation with TNF for 6 h.
Coexpression of the ABIN-1-MUTs with wild type ABIN-1
clearly interferes with the NF-UB inhibiting e¡ect of ABIN-1.
In contrast, A20 retains its NF-UB inhibiting function even in
the presence of high expression levels of ABIN-1-MUTs (Fig.
3A). As shown by Western blotting, these e¡ects are not due
to altered expression levels of wild type ABIN-1 or A20 (Fig.
3B). These results further demonstrate the importance of the
AHD2 sequence in the NF-UB inhibitory function of ABIN-1.
Furthermore, the observation that coexpression of inactive
ABIN-1 mutants carrying a speci¢c mutation in their AHD2
region with wild type ABIN-1 or A20 speci¢cally prevents the
e¡ect of ABIN-1 but not of A20 indicates that A20 can func-
tion independently of ABIN-1.
3.3. A20 binding is not required for NF-UB inhibition by
ABIN-1
To further analyze if the NF-UB inhibiting function of the
ABIN-1 fragments is correlated with their interaction with
A20, coimmunoprecipitation analysis was performed. There-
fore HEK293T cells were transiently transfected with FLAG-
tagged A20 with an empty vector as a negative control, or
with vectors encoding the di¡erent E-tagged ABIN-1 mutants.
Coimmunoprecipitation was performed using anti-E tag anti-
bodies and coimmunoprecipitating A20 was revealed with
anti-FLAG-tagged antibodies. This demonstrated that
ABIN-1(420^647), which corresponds to the C-terminal do-
main lacking the leucine zipper structure, interacts with higher
e⁄ciency with A20 compared to ABIN-1(390^647), which was
previously designated the A20 interacting domain [9]. In con-
trast, the minimal ABIN-1 fragment that still inhibits NF-UB
activation (ABIN-1(444^601)) does not interact with A20
(Fig. 4A), indicating that interaction with A20 is not required
for the NF-UB inhibiting function of ABIN-1. On the other
hand, site-speci¢c mutants of ABIN-1 without NF-UB inhib-
iting activity still interact with A20 (Fig. 4B). Consequently,
although the AHD2 domain is necessary for the NF-UB in-
hibiting function of ABIN-1, this region is not the A20 inter-
acting domain. Similarly, also the AHD2-like sequence in
IKKQ is not involved in A20 IKKQ binding. In this case,
A20 binding was localized in a region spanning amino acids
95^218, which does not include the homologous AHD2 region
(aa 300^322) [18]. Conversely, the interaction of A20 with
IKKQ and ABIN-1 seems to be mediated by di¡erent domains
in A20 [19], further demonstrating that the homologous
AHD2 region is not an A20 interaction domain. Alignment
of the amino acid sequences of the ABIN proteins revealed
the presence of another conserved amino acid stretch, referred
to as AHD1, which is however absent in IKKQ and NRP. Via
deletion analysis of ABIN-1 we obtained evidence that AHD1
is involved in the interaction of ABIN-1 with A20 (Fig. 4A).
The absence of a correlation between A20 binding and NF-UB
inhibition further indicates that interaction with A20 is not
required for NF-UB inhibition by ABIN-1. At this moment,
the biological signi¢cance of the interaction of A20 with
ABIN-1 remains unknown.
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